Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1448310-20-0

Post Buying Request

1448310-20-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1448310-20-0 Usage

Explanation

PPYPCA is composed of 10 carbon atoms, 7 hydrogen atoms, 5 nitrogen atoms, and 2 oxygen atoms.
2. Heterocyclic compound

Explanation

PPYPCA contains multiple rings with different elements, specifically a pyrimidine and a pyrazole ring.
3. Pyrimidine ring

Explanation

A six-membered aromatic ring containing four carbon atoms and two nitrogen atoms.
4. Pyrazole ring

Explanation

A five-membered aromatic ring containing three carbon atoms and two nitrogen atoms.
5. Carboxylic acid group

Explanation

A functional group consisting of a carbonyl group (C=O) and a hydroxyl group (-OH) attached to the same carbon atom.
6. Potential pharmaceutical applications

Explanation

PPYPCA's unique structure and properties make it a promising candidate for the development of new drugs targeting specific biological pathways.
7. Research and development

Explanation

Due to its potential applications in the pharmaceutical industry, PPYPCA is a subject of interest for further research and development.

Check Digit Verification of cas no

The CAS Registry Mumber 1448310-20-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,4,8,3,1 and 0 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1448310-20:
(9*1)+(8*4)+(7*4)+(6*8)+(5*3)+(4*1)+(3*0)+(2*2)+(1*0)=140
140 % 10 = 0
So 1448310-20-0 is a valid CAS Registry Number.

1448310-20-0Downstream Products

1448310-20-0Relevant articles and documents

CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF

-

Paragraph 1478, (2018/04/17)

Disclosed herein are small molecule calpain modulator compositions, pharmaceutical compositions, the use and preparation thereof.

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

-

Page/Page column 111-112, (2013/07/31)

Provided are methods of treating a cancer characterized by the presence of a mutant allele of IDH1/2 comprising administering to a subject in need thereof a compound described here.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1448310-20-0